[1] Chen BY,Wang X,Chen LW,et al. Molecular targeting regulation of proliferation and differentiation of the bone marrow-derived mesenchymal stem cells or mesenchymal stromal cells. Curr Drug Targets,2012,13（4）:561-571.
[2] Lyu FJ,Tuan RS,Cheung KM,et al. Concise review:the surface markers and identity of human mesenchymal stem cells. Stem cells,2014,32（6）:1408-1419.
[3] Penny J,Harris P,Shakesheff KM,et al. The biology of equine mesenchymal stem cells:phenotypic characterization,cell surface markers and multilineage differentiation. Front Biosci,2012,17（3）:892.
[4] Chen ML,Lee KD,Huang HC,et al. HNF-4α determines hepatic differentiation of human mesenchymal stem cells from bone marrow. World J Gastroenterol,2010,16（40）:5092-5103.
[5] Lin BL,Chen JF,Qiu WH,et al. Allogeneic bone marrow-derived mesenchymal stromal cells for HBV-related acute-on -chronic liver failure:a randomized controlled trial. Hepatology,2017,[ahead of print].
[6] 孙文静,陈东风. 间充质干细胞治疗在肝病中的应用. 胃肠病学和肝病学杂志,2012,21（6）:491-494.
[7] Wen J,Zhang JQ,Huang W,et al. SDF-1α and CXCR4 as therapeutic targets in cardiovascular disease. Am J Cardiovasc Dis,2012,2（1）:20-28.
[8] Zhu M,Feng Q,Bian L. Differential effect of hypoxia on human mesenchymal stem cell chondrogenesis and hypertrophy in hyaluronic acid hydrogels. Acta Biomaterialia,2014,10（3）:1333.
[9] Wei C,Miao L,Su G,et al. Co-transplantation of hematopoietic stem cells and Cxcr4 gene-transduced mesenchymal stem cells promotes hematopoiesis. Cell Biochem Biophy,2015,71（3）:1579-1587.
[10] Gardner OF,Fahy N,Alini M,et al. Differences in human mesenchymal stem cell secretomes during chondrogenic induction. Eur Cell Mater,2016,31:221.
[11] 郑林华, 韩英. 骨髓干细胞对终末期肝病治疗的临床研究进展. 中华细胞与干细胞杂志:电子版,2015,5（2）:53-57.
[12] Alison MR,Poulsom R,Jeffery R,et al. Hepatocytes from non-hepatic adult stem cells. Nature,2000,406（6793）:257.
[13] Margini C,Vukotic R,Brodosi L,et al. Bone marrow derived stem cells for the treatment of end-stage liver disease. World J Gastroenterol,2014,20（27）:9098.
[14] Trautwein C,Friedman SL,Schuppan D,et al. Hepatic fibrosis: Concept to treatment. J Hepatol,2015,62（1S）:S15-S24.
[15] Chen S,Xu L,Lin N,et al. Activation of Notch1 signaling by marrow-derived mesenchymal stem cells through cell-cell contact inhibits proliferation of hepatic stellate cells. Lif Sci,2011,89（25-26）:975-981.
[16] Ren J,Jin P,Sabatino M,et al. Global transcriptome analysis of human bone Marrow stromal cells （BMSCs） reveals proliferative,mobile,and interactive cells that produce abundant extracellular matrix proteins,some of which may affect BMSC Potency. Cytotherapy,2011,13（6）:661-674.
[17] Deng X,Chen Y X,Zhang X,et al. Hepatic stellate cells modulate the differentiation of bone marrow mesenchymal stem cells into hepatocyte-like cells. J Cell Physiol,2008,217（1）:138.
[18] Russo FP,Alison MR,Bigger BW,et al. The bone marrow functionally contributes to liver fibrosis. Gastroenterology,2006,130（6）:1807-1821.
[19] 黄从云,彭淑牖. 肝硬化与肝脏免疫系统. 国际外科学杂志, 2004,31（2）:102-105.
[20] Bertolino P,Klimpel G,Lemon SM. Hepatic inflammation and immunity:a summary of a conference on the function of the immune system within the liver. Hepatology,2000,31（6）:1374-1378.
[21] Gale RP,Sparkes RS,Golde DW. Bone marrow origin of hepatic macrophages（Kupffer cells） in humans. Science,1978,201（4359）:937-938.
[22] Ziegler P,Boettcher S,Takizawa H. LPS-stimulated human bone marrow stroma cells support myeloid cell development and progenitor cell maintenance. Ann Hematol,2016,95（2）:173-178.
[23] 王焕丽,熊兵,陈华德,等. 骨髓间充质干细胞对巨噬细胞分泌炎症因子的影响. 南方医科大学学报,2014,34（9）:1259-1264. |
